A chilling trend is emerging across the United States: widespread vaccine hesitancy. More than three-quarters of adults skipped the COVID-19 vaccine last season, and health experts fear that number will climb, fueled by shifting federal guidance and a growing tide of misinformation.
Initially, the COVID-19 vaccine was met with eager acceptance. By early 2022, roughly 75% of Americans had received at least one dose of the original vaccines. This represented a powerful, collective effort to combat a terrifying new threat.
However, the landscape has dramatically changed. During the 2024-2025 season, a mere 23% of adults sought COVID-19 vaccination – a stark contrast to the 47% who received a flu shot. This decline isn’t isolated; vaccination rates for common illnesses like the flu, measles, and tetanus are also falling.
Despite waning vaccination numbers, COVID-19 remains a serious, potentially fatal risk. Last year alone, it was listed on over 31,400 death certificates. For comparison, influenza accounted for approximately 6,500 deaths, while pneumonia – often a complication of the flu – caused another 41,600.
Public health researchers are deeply concerned about further declines, particularly among Latino, African American, and younger populations. These groups already experience lower immunization rates and are disproportionately vulnerable to long-term COVID complications.
Recent policy shifts have contributed to the confusion. Under the current administration, federal recommendations regarding the COVID-19 vaccine have become more restrictive, creating a patchwork of access rules across the country. States with Republican leadership often present greater barriers to vaccination.
“There’s a lot of misinformation circulating about COVID,” explains Alein Haro-Ramos, a health behavior scientist. “Distrust of the vaccine is going to increase.” This distrust is eroding the foundation of public health protection.
The Food and Drug Administration recently limited COVID-19 vaccine approval to those 65 and older, and adults and children with underlying medical conditions. This decision was followed by a CDC advisory committee recommending a “shared clinical decision,” moving away from a general recommendation for all adults.
This guidance has been met with criticism from infectious disease experts, who argue that most adults and children should receive both the flu and COVID-19 vaccines, given their safety, effectiveness, and ability to prevent severe illness. Independent medical organizations continue to advocate for widespread vaccination.
Over twenty states are working to ensure broad access to COVID-19 vaccines in pharmacies without a prescription, often aligning with scientific recommendations. Many also mandate insurance coverage of the vaccines without cost-sharing.
Fear of side effects, concerns about long-term consequences, doubts about efficacy, and distrust of pharmaceutical companies and authorities are key drivers of vaccine refusal. These anxieties are deeply rooted and complex.
Data reveals that vaccine hesitancy is particularly pronounced among Latinos, African Americans, uninsured individuals, and those living in politically conservative states. Latino adults exhibit significantly lower vaccination rates than other racial and ethnic groups, hovering around 15%.
This disparity may stem from a combination of factors, including a younger demographic within the Latino population and lingering fears related to past immigration policies. Previous administrations linked Medicaid access to the “public charge” rule, potentially deterring some from seeking healthcare services.
Haro-Ramos’ research highlights the deep-seated anxieties within the Latino community. “Do you trust the healthcare system in general? Are you willing to give your information – your name, your address?” she asks. “Trust is key.”
These concerns have been amplified by recent policy changes. The current administration’s decision to share personal data from Medicaid recipients with Immigration and Customs Enforcement has prompted many Latinos to avoid medical appointments altogether.
“People are avoiding leaving their homes at all costs,” Haro-Ramos states, painting a picture of growing fear and isolation. The consequences of this fear are far-reaching.
A recent study focusing on African Americans in Georgia found that participants relied heavily on their healthcare providers for vaccination advice, dismissing information from religious leaders or peers. However, those who remained unvaccinated were more likely to believe in misinformation, such as claims that the vaccine causes infertility or contains microchips.
“Doctors are the ones who can explain that those ideas about the vaccine are myths,” explains Janani Rajbhandari-Thapa, a public health researcher. The role of trusted medical professionals is paramount in combating false narratives.
While hospitalization and death rates from COVID-19 have decreased, severe complications remain more common among older individuals. Last year, nearly 89% of COVID-19 deaths in the U.S. occurred in people aged 65 or older.
Many young adults have developed a sense of invulnerability as the pandemic fades. Only 11% of Americans aged 18-29 received a COVID-19 vaccine during the 2024-2025 season – the lowest rate among all adult age groups. This represents a dangerous shift in perception.
Some mistakenly believe the vaccine is ineffective because they contracted COVID-19 despite being vaccinated. Otto Yang, an infectious disease specialist, clarifies that the vaccine’s primary purpose is to prevent severe illness, hospitalization, and death – and it excels at that task.
“They think: ‘Well, I got COVID despite the vaccine, so it didn’t work,’” Yang explains. “And what they don’t see is that the vaccine prevented them from getting seriously ill, which is the most important thing.” The vaccine also offers protection against long-term COVID symptoms.
Ultimately, Yang argues, there’s no logical reason to get a flu shot and skip the COVID-19 vaccine. Both are safe, effective, and prevent serious illness. Individuals with compromised immune systems and those at higher risk should prioritize COVID-19 vaccination, while the decision for others is “a little less clear,” but generally leans towards vaccination, similar to the flu.
